NEWS
March 3, 2010
Ranbaxy Unable to Launch New Generic, Shares Fall
Ranbaxy Laboratories said on Wednesday it would not be able to launch a generic urinary drug as per schedule in the absence of a final regulatory approval, sending its shares down more than 6 percent...
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|